Literature DB >> 1384659

Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors.

C Desmaze1, J Zucman, O Delattre, G Thomas, A Aurias.   

Abstract

The chromosome 22 breakpoint of the t(11;22) translocation of peripheral neuroepithelioma has been located, by fluorescence in situ hybridization, in the proximity of the interface between 22q12.1 and 22q12.2. Use of single cosmids or pools of cosmids of the flanking regions enables the monitoring of the translocation in interphase and in metaphase chromosomes. This method can now be routinely applied for the diagnosis of this translocation in mixed round cell tumors.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1384659     DOI： 10.1002/gcc.2870050105

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


  11 in total

1.  A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.

Authors:  U Yamaguchi; T Hasegawa; Y Morimoto; U Tateishi; M Endo; F Nakatani; A Kawai; H Chuman; Y Beppu; M Endo; H Kurotaki; K Furuta
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

2.  Molecular Approaches to Diagnosis in Ewing Sarcoma: Fluorescence In Situ Hybridization (FISH).

Authors:  Marcel Trautmann; Wolfgang Hartmann
Journal:  Methods Mol Biol       Date:  2021

3.  Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma.

Authors:  J Shipley; J Crew; S Birdsall; S Gill; J Clark; C Fisher; A Kelsey; T Nojima; H Sonobe; C Cooper; B Gusterson
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

4.  Precise localization on chromosome 12 of the ATF-1 gene by fluorescence in situ hybridization.

Authors:  C Desmaze; J Zucman; O Delattre; T Melot; G Thomas; A Aurias
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

5.  FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.

Authors:  Liu Yang; Hsien-Ming Hu; Anna Zielinska-Kwiatkowska; Howard A Chansky
Journal:  Biochem Biophys Res Commun       Date:  2010-10-08       Impact factor: 3.575

Review 6.  Ewing's sarcoma.

Authors:  P A Meyers; A S Levy
Journal:  Curr Treat Options Oncol       Date:  2000-08

Review 7.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

Review 8.  Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

9.  Progress in the molecular biology of ewing tumors.

Authors:  H Kovar
Journal:  Sarcoma       Date:  1998

10.  Combinatorial generation of variable fusion proteins in the Ewing family of tumours.

Authors:  J Zucman; T Melot; C Desmaze; J Ghysdael; B Plougastel; M Peter; J M Zucker; T J Triche; D Sheer; C Turc-Carel
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.